HbA1c: A useful cardiovascular risk marker in those without diabetes?

Diabetologia

Volumn 53, Issue 12, 2010, Pages 2468-2469

  Preiss, D ^a   Sattar, N ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiovascular disease; Diabetes; HbA1c; Risk prediction

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; NATEGLINIDE; PLACEBO; VALSARTAN; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; NOTE; PATIENT MONITORING; POSTPRANDIAL STATE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; BLOOD; CASE CONTROL STUDY; EVALUATION; METABOLISM; PHYSIOLOGY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 78649335650     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1902-x     Document Type: Note

References (9)

1. N Sarwar P Gao SR Seshasai, et al. 2010 Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 375 2215 2222 1:CAS:528:DC%2BC3cXotVagtr0%3D 10.1016/S0140-6736(10)60484-9 20609967
2. N Sarwar T Aspelund G Eiriksdottir, et al. 2010 Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review PLoS Med 7 e1000278 10.1371/journal. pmed.1000278 20520805
3. E Selvin MW Steffes H Zhu, et al. 2010 Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 800 811 1:CAS:528:DC%2BC3cXivV2hu7Y%3D 10.1056/NEJMoa0908359 20200384
4. HC Gerstein S Islam S Anand, et al. 2010 Dysglycemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15780 patients from the INTERHEART study Diabetologia 10.1007/s00125-010-1871-0
5. RK Simmons S Sharp SM Boekholdt, et al. 2008 Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? Arch Intern Med 168 1209 1216 10.1001/archinte.168.11.1209 18541829 (Pubitemid 351831404)
6. KK Ray SR Seshasai S Wijesuriya, et al. 2009 Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 1765 1772 1:CAS:528:DC%2BD1MXmtleksbc%3D 10.1016/S0140-6736(09)60697-8 19465231
7. RR Holman SM Haffner JJ McMurray, et al. 2010 Effect of nateglinide on the incidence of diabetes and cardiovascular events N Engl J Med 362 1463 1476 1:CAS:528:DC%2BC3cXlt12ksLg%3D 10.1056/NEJMoa1001122 20228402
8. American Diabetes Association 2010 Diagnosis and classification of diabetes mellitus Diab Care 33 Suppl 1 S62 S69 10.2337/dc10-S062
9. E Di Angelantonio N Sarwar P Perry, et al. 2009 Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 1993 2000 10.1001/jama.2009.1619 19903920